Tag: biOasis Technologies

July 16, 2018

Bioasis Announces Non-Brokered Private Placement

Bioasis Technologies (TSXV:BTI) has announced its intentions to pursue a non-brokered private placement of units at $0.552 per unit for...
July 11, 2018

Bioasis and BioAgilytix Announce Strategic Collaboration to Advance xB3 TM-001, Bioasis’ Lead Investigational Candidate to Treat HER2+ Brain Cancer, to IND Submission and into the Clinic

BIOASIS TECHNOLOGIES (TSX.V:BTI; OTCQB:BIOAF), a biopharmaceutical company developing its xB3 TM proprietary platform technology for the delivery of therapeutics across the blood-brain...
June 14, 2017

CEO of biOasis Technologies Gives Update to Shareholders

The CEO of biOasis Technologies issued a message to shareholders for the advancement of the Transcend Platform and the company's...
April 25, 2017

biOasis Technologies Appoints New CEO

biOasis Technologies announced the appointment of Dr. Mark Day as president and CEO of the company.
April 13, 2017

An Introduction to TSXV Life Science Stocks

Should you decide that the TSXV is right for you, the Investing News Network has compiled a list of some...